Modeling health benefits and harms of public policy responses to the US opioid epidemic

AL Pitt, K Humphreys… - American journal of …, 2018 - ajph.aphapublications.org
Objectives. To estimate health outcomes of policies to mitigate the opioid epidemic.
Methods. We used dynamic compartmental modeling of US adults, in various pain, opioid …

[PDF][PDF] Abuse-deterrent opioid formulations

RS Litman, OH Pagán, TJ Cicero - Anesthesiology, 2018 - academia.edu
Abuse-deterrent opioid formulations have been suggested as one way to decrease the
abuse, addiction, and overdose of orally prescribed opioids. Ten oral opioid formulations …

Abuse-deterrent opioids: an update on current approaches and considerations

JV Pergolizzi Jr, RB Raffa, R Taylor Jr… - … medical research and …, 2018 - Taylor & Francis
Objective: Abuse and misuse of prescription opioids is a significant public health concern.
This review examines the strategies used to confer abuse-deterrent properties on opioid …

Abuse deterrent immediate release egg-shaped tablet (Egglets) using 3D printing technology: quality by design to optimize drug release and extraction

PK Nukala, S Palekar, M Patki, K Patel - Aaps Pharmscitech, 2019 - Springer
Opioid abuse is a growing problem and has become a national health crisis over the past
decade in the USA. Oral ingestion, snorting, and injection are the most commonly employed …

Abuse-deterrent formulations and opioid-related harms in North Carolina, 2010-2018

BL DiPrete, N Dasgupta, GY Oh… - American Journal of …, 2024 - academic.oup.com
Abuse-deterrent formulations of opioid analgesics (ADFs) were introduced to reduce opioid-
related harms among pain patients, but postmarketing study results have been mixed …

[HTML][HTML] Medical outcomes associated with prescription opioid abuse via oral and non-oral routes of administration

JL Green, BB Bartelson, MC Le Lait, CL Roland… - Drug and alcohol …, 2017 - Elsevier
Background Prescription opioid abuse and misuse is a serious and growing public health
issue. While the most common form of abuse is swallowing intact tablets/capsules, some …

[HTML][HTML] Assessment of tapentadol API abuse liability with the researched abuse, diversion and addiction-related surveillance system

SK Vosburg, SG Severtson, RC Dart, TJ Cicero… - The Journal of …, 2018 - Elsevier
Tapentadol, a Schedule II opioid with a combination of µ-opioid activity and norepinephrine
reuptake inhibition, is used for the management of moderate to severe acute and chronic …

Law enforcement‐derived data on gabapentin diversion and misuse, 2002‐2015: diversion rates and qualitative research findings

ME Buttram, SP Kurtz, RC Dart… - … and drug safety, 2017 - Wiley Online Library
Purpose Recent limited epidemiologic and case reports suggest that gabapentin is being
misused, especially among prescription opioid misusers. However, no apparent studies …

Abuse and diversion of immediate release opioid analgesics as compared to extended release formulations in the United States

JL Iwanicki, SG Severtson, H McDaniel, A Rosenblum… - PLoS …, 2016 - journals.plos.org
Background Therapeutic use and abuse of prescription opioids in the United States
increased substantially between 1990 and 2010. The Centers for Disease Control estimated …

Non-medical use of prescription stimulants among college students: non-oral routes of administration, risk factors, motivations, and pathways

SF Butler, SV Faraone, AL Rostain, JH Newcorn… - Frontiers in …, 2021 - frontiersin.org
Introduction: Non-medical use (NMU) of prescription stimulant medications is a continuing
public health concern. Stimulant medications prescribed for attention-deficit/hyperactivity …